Measures will only be used when it is absolutely necessary.
-
-
NMIBC: intravesical chemoablation fails phase 2 Chemoablation was associated with lower subsequent recurrences in nonresponders.
-
The European Medicines Agency recommends a coordinated approach to large-scale randomised clinical trials against COVID-19
-
What do kids confined to home think about the 2020 COVID-19 pandemic? A firsthand account of children's reactions to the sudden need of home schooling due to COVID-19
-
A new standard of care for upper urinary tract carcinoma Findings from the POUT trial published in Lancet
-
ESMO guidelines on diagnosing and treating cancer-related fatigue The European Society for Medical Oncology says healthcare professionals should acknowledge the reality and impact of cancer-related fatigue
-
Findings from a global review.
-
Prostate cancer: SBRT consecutive day and weekly regimens are safe Both schedules show favorable biochemical control rates and maintain QoL.
-
The ‘Solidarity’ vaccine trial begins just 60 days after genetic sequence was shared.
-
Frequent antibiotic use and the risk of infection-related hospital admissions A strong dose-response was found between the patterns of changes in hospitalisation risk and level of prior antibiotic use
-
TAP block briefly reduces pain after laparoscopic prostatectomy The effect was short-lived and did not reduce 24-hour fentanyl consumption.
-
HIV and COVID-19: BHIVA issues briefing. People with controlled HIV are not thought to be at increased risk, and there is no shortage of HIV medication, BHIVA says.
-
Only urgent inspections to continue.
-
A systematic review and meta-analysis.